Not Perfect, But Worth a Shot

After 3 decades of research, Ghana, Kenya, and Malawi are piloting the first malaria vaccine in babies.
The vaccine is only about 40% effective, but Mosquirix is being given a shot anyway amid rising resistance to treatment and stalling progress against the disease.
Mosquirix (also known by its scientific name, RTS,S) was WHO-approved in 2015, but this pilot program will confirm whether it should be rolled out widely.
It’s too early to know if it’s working, but one Malawi clinic clocked just 40 malaria cases in the first 5 months of the program compared to 78 in the same period of 2018.

Comments +


Post a Comment

Restricted HTML

  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Back to top